Global CGRP Targeting Drugs for Migraine Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The main principle of drugs targeting CGRP for Migraine is to inhibit the biological effects of CGRP by blocking the binding of CGRP to its receptors, thereby achieving the purpose of treatment.
The global CGRP Targeting Drugs for Migraine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “CGRP Targeting Drugs for Migraine Industry Forecast” looks at past sales and reviews total world CGRP Targeting Drugs for Migraine sales in 2022, providing a comprehensive analysis by region and market sector of projected CGRP Targeting Drugs for Migraine sales for 2023 through 2029. With CGRP Targeting Drugs for Migraine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CGRP Targeting Drugs for Migraine industry.
This Insight Report provides a comprehensive analysis of the global CGRP Targeting Drugs for Migraine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CGRP Targeting Drugs for Migraine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CGRP Targeting Drugs for Migraine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CGRP Targeting Drugs for Migraine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CGRP Targeting Drugs for Migraine.
United States market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key CGRP Targeting Drugs for Migraine players cover AbbVie Inc., Pfizer Inc., Lundbeck, Alder Therapeutics, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of CGRP Targeting Drugs for Migraine market by product type, application, key players and key regions and countries.
Segmentation by Type:
The main principle of drugs targeting CGRP for Migraine is to inhibit the biological effects of CGRP by blocking the binding of CGRP to its receptors, thereby achieving the purpose of treatment.
The global CGRP Targeting Drugs for Migraine market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “CGRP Targeting Drugs for Migraine Industry Forecast” looks at past sales and reviews total world CGRP Targeting Drugs for Migraine sales in 2022, providing a comprehensive analysis by region and market sector of projected CGRP Targeting Drugs for Migraine sales for 2023 through 2029. With CGRP Targeting Drugs for Migraine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world CGRP Targeting Drugs for Migraine industry.
This Insight Report provides a comprehensive analysis of the global CGRP Targeting Drugs for Migraine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on CGRP Targeting Drugs for Migraine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global CGRP Targeting Drugs for Migraine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for CGRP Targeting Drugs for Migraine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global CGRP Targeting Drugs for Migraine.
United States market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for CGRP Targeting Drugs for Migraine is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key CGRP Targeting Drugs for Migraine players cover AbbVie Inc., Pfizer Inc., Lundbeck, Alder Therapeutics, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of CGRP Targeting Drugs for Migraine market by product type, application, key players and key regions and countries.
Segmentation by Type:
- CGRP Receptor Antagonists
- CGRP Monoclonal Antibodies
- Hospital
- Specialty Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- CGRP Receptor Antagonists
- CGRP Monoclonal Antibodies
- Hospital
- Specialty Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie Inc.
- Pfizer Inc.
- Lundbeck
- Alder Therapeutics
- Teva
- Lilly Inc.
- Amgen Inc.
- Novartis International AG
- Daiichi Sankyo Co., Ltd.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CGRP Targeting Drugs for Migraine Market Size 2019-2030
2.1.2 CGRP Targeting Drugs for Migraine Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for CGRP Targeting Drugs for Migraine by Country/Region, 2019, 2023 & 2030
2.2 CGRP Targeting Drugs for Migraine Segment by Type
2.2.1 CGRP Receptor Antagonists
2.2.2 CGRP Monoclonal Antibodies
2.3 CGRP Targeting Drugs for Migraine Market Size by Type
2.3.1 CGRP Targeting Drugs for Migraine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CGRP Targeting Drugs for Migraine Market Size Market Share by Type (2019-2024)
2.4 CGRP Targeting Drugs for Migraine Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Others
2.5 CGRP Targeting Drugs for Migraine Market Size by Application
2.5.1 CGRP Targeting Drugs for Migraine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CGRP Targeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
3 CGRP TARGETING DRUGS FOR MIGRAINE MARKET SIZE BY PLAYER
3.1 CGRP Targeting Drugs for Migraine Market Size Market Share by Player
3.1.1 Global CGRP Targeting Drugs for Migraine Revenue by Player (2019-2024)
3.1.2 Global CGRP Targeting Drugs for Migraine Revenue Market Share by Player (2019-2024)
3.2 Global CGRP Targeting Drugs for Migraine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CGRP TARGETING DRUGS FOR MIGRAINE BY REGION
4.1 CGRP Targeting Drugs for Migraine Market Size by Region (2019-2024)
4.2 Global CGRP Targeting Drugs for Migraine Annual Revenue by Country/Region (2019-2024)
4.3 Americas CGRP Targeting Drugs for Migraine Market Size Growth (2019-2024)
4.4 APAC CGRP Targeting Drugs for Migraine Market Size Growth (2019-2024)
4.5 Europe CGRP Targeting Drugs for Migraine Market Size Growth (2019-2024)
4.6 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024)
5.2 Americas CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024)
5.3 Americas CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CGRP Targeting Drugs for Migraine Market Size by Region (2019-2024)
6.2 APAC CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024)
6.3 APAC CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024)
7.2 Europe CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024)
7.3 Europe CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CGRP Targeting Drugs for Migraine by Region (2019-2024)
8.2 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024)
8.3 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CGRP TARGETING DRUGS FOR MIGRAINE MARKET FORECAST
10.1 Global CGRP Targeting Drugs for Migraine Forecast by Region (2025-2030)
10.1.1 Global CGRP Targeting Drugs for Migraine Forecast by Region (2025-2030)
10.1.2 Americas CGRP Targeting Drugs for Migraine Forecast
10.1.3 APAC CGRP Targeting Drugs for Migraine Forecast
10.1.4 Europe CGRP Targeting Drugs for Migraine Forecast
10.1.5 Middle East & Africa CGRP Targeting Drugs for Migraine Forecast
10.2 Americas CGRP Targeting Drugs for Migraine Forecast by Country (2025-2030)
10.2.1 United States Market CGRP Targeting Drugs for Migraine Forecast
10.2.2 Canada Market CGRP Targeting Drugs for Migraine Forecast
10.2.3 Mexico Market CGRP Targeting Drugs for Migraine Forecast
10.2.4 Brazil Market CGRP Targeting Drugs for Migraine Forecast
10.3 APAC CGRP Targeting Drugs for Migraine Forecast by Region (2025-2030)
10.3.1 China CGRP Targeting Drugs for Migraine Market Forecast
10.3.2 Japan Market CGRP Targeting Drugs for Migraine Forecast
10.3.3 Korea Market CGRP Targeting Drugs for Migraine Forecast
10.3.4 Southeast Asia Market CGRP Targeting Drugs for Migraine Forecast
10.3.5 India Market CGRP Targeting Drugs for Migraine Forecast
10.3.6 Australia Market CGRP Targeting Drugs for Migraine Forecast
10.4 Europe CGRP Targeting Drugs for Migraine Forecast by Country (2025-2030)
10.4.1 Germany Market CGRP Targeting Drugs for Migraine Forecast
10.4.2 France Market CGRP Targeting Drugs for Migraine Forecast
10.4.3 UK Market CGRP Targeting Drugs for Migraine Forecast
10.4.4 Italy Market CGRP Targeting Drugs for Migraine Forecast
10.4.5 Russia Market CGRP Targeting Drugs for Migraine Forecast
10.5 Middle East & Africa CGRP Targeting Drugs for Migraine Forecast by Region (2025-2030)
10.5.1 Egypt Market CGRP Targeting Drugs for Migraine Forecast
10.5.2 South Africa Market CGRP Targeting Drugs for Migraine Forecast
10.5.3 Israel Market CGRP Targeting Drugs for Migraine Forecast
10.5.4 Turkey Market CGRP Targeting Drugs for Migraine Forecast
10.6 Global CGRP Targeting Drugs for Migraine Forecast by Type (2025-2030)
10.7 Global CGRP Targeting Drugs for Migraine Forecast by Application (2025-2030)
10.7.1 GCC Countries Market CGRP Targeting Drugs for Migraine Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Information
11.1.2 AbbVie Inc. CGRP Targeting Drugs for Migraine Product Offered
11.1.3 AbbVie Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Inc. Main Business Overview
11.1.5 AbbVie Inc. Latest Developments
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Information
11.2.2 Pfizer Inc. CGRP Targeting Drugs for Migraine Product Offered
11.2.3 Pfizer Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Inc. Main Business Overview
11.2.5 Pfizer Inc. Latest Developments
11.3 Lundbeck
11.3.1 Lundbeck Company Information
11.3.2 Lundbeck CGRP Targeting Drugs for Migraine Product Offered
11.3.3 Lundbeck CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Lundbeck Main Business Overview
11.3.5 Lundbeck Latest Developments
11.4 Alder Therapeutics
11.4.1 Alder Therapeutics Company Information
11.4.2 Alder Therapeutics CGRP Targeting Drugs for Migraine Product Offered
11.4.3 Alder Therapeutics CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Alder Therapeutics Main Business Overview
11.4.5 Alder Therapeutics Latest Developments
11.5 Teva
11.5.1 Teva Company Information
11.5.2 Teva CGRP Targeting Drugs for Migraine Product Offered
11.5.3 Teva CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Teva Main Business Overview
11.5.5 Teva Latest Developments
11.6 Lilly Inc.
11.6.1 Lilly Inc. Company Information
11.6.2 Lilly Inc. CGRP Targeting Drugs for Migraine Product Offered
11.6.3 Lilly Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Lilly Inc. Main Business Overview
11.6.5 Lilly Inc. Latest Developments
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Information
11.7.2 Amgen Inc. CGRP Targeting Drugs for Migraine Product Offered
11.7.3 Amgen Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amgen Inc. Main Business Overview
11.7.5 Amgen Inc. Latest Developments
11.8 Novartis International AG
11.8.1 Novartis International AG Company Information
11.8.2 Novartis International AG CGRP Targeting Drugs for Migraine Product Offered
11.8.3 Novartis International AG CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis International AG Main Business Overview
11.8.5 Novartis International AG Latest Developments
11.9 Daiichi Sankyo Co., Ltd.
11.9.1 Daiichi Sankyo Co., Ltd. Company Information
11.9.2 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Product Offered
11.9.3 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Daiichi Sankyo Co., Ltd. Main Business Overview
11.9.5 Daiichi Sankyo Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. CGRPTargeting Drugs for Migraine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. CGRPTargeting Drugs for Migraine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CGRP Receptor Antagonists
Table 4. Major Players of CGRP Monoclonal Antibodies
Table 5. CGRPTargeting Drugs for Migraine Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 7. Global CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Table 8. CGRPTargeting Drugs for Migraine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 10. Global CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Table 11. Global CGRPTargeting Drugs for Migraine Revenue by Player (2019-2024) & ($ millions)
Table 12. Global CGRPTargeting Drugs for Migraine Revenue Market Share by Player (2019-2024)
Table 13. CGRPTargeting Drugs for Migraine Key Players Head office and Products Offered
Table 14. CGRPTargeting Drugs for Migraine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CGRPTargeting Drugs for Migraine Market Size by Region (2019-2024) & ($ millions)
Table 18. Global CGRPTargeting Drugs for Migraine Market Size Market Share by Region (2019-2024)
Table 19. Global CGRPTargeting Drugs for Migraine Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global CGRPTargeting Drugs for Migraine Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas CGRPTargeting Drugs for Migraine Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas CGRPTargeting Drugs for Migraine Market Size Market Share by Country (2019-2024)
Table 23. Americas CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 24. Americas CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Table 25. Americas CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Table 27. APAC CGRPTargeting Drugs for Migraine Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC CGRPTargeting Drugs for Migraine Market Size Market Share by Region (2019-2024)
Table 29. APAC CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 30. APAC CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe CGRPTargeting Drugs for Migraine Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe CGRPTargeting Drugs for Migraine Market Size Market Share by Country (2019-2024)
Table 33. Europe CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 34. Europe CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 37. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CGRPTargeting Drugs for Migraine
Table 39. Key Market Challenges & Risks of CGRPTargeting Drugs for Migraine
Table 40. Key IndustryTrends of CGRPTargeting Drugs for Migraine
Table 41. Global CGRPTargeting Drugs for Migraine Market SizeForecast by Region (2025-2030) & ($ millions)
Table 42. Global CGRPTargeting Drugs for Migraine Market Size Market ShareForecast by Region (2025-2030)
Table 43. Global CGRPTargeting Drugs for Migraine Market SizeForecast byType (2025-2030) & ($ millions)
Table 44. Global CGRPTargeting Drugs for Migraine Market SizeForecast by Application (2025-2030) & ($ millions)
Table 45. AbbVie Inc. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 46. AbbVie Inc. CGRPTargeting Drugs for Migraine Product Offered
Table 47. AbbVie Inc. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. AbbVie Inc. Main Business
Table 49. AbbVie Inc. Latest Developments
Table 50. Pfizer Inc. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 51. Pfizer Inc. CGRPTargeting Drugs for Migraine Product Offered
Table 52. Pfizer Inc. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Pfizer Inc. Main Business
Table 54. Pfizer Inc. Latest Developments
Table 55. Lundbeck Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 56. Lundbeck CGRPTargeting Drugs for Migraine Product Offered
Table 57. Lundbeck CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Lundbeck Main Business
Table 59. Lundbeck Latest Developments
Table 60. AlderTherapeutics Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 61. AlderTherapeutics CGRPTargeting Drugs for Migraine Product Offered
Table 62. AlderTherapeutics CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. AlderTherapeutics Main Business
Table 64. AlderTherapeutics Latest Developments
Table 65.Teva Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 66.Teva CGRPTargeting Drugs for Migraine Product Offered
Table 67.Teva CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68.Teva Main Business
Table 69.Teva Latest Developments
Table 70. Lilly Inc. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 71. Lilly Inc. CGRPTargeting Drugs for Migraine Product Offered
Table 72. Lilly Inc. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Lilly Inc. Main Business
Table 74. Lilly Inc. Latest Developments
Table 75. Amgen Inc. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 76. Amgen Inc. CGRPTargeting Drugs for Migraine Product Offered
Table 77. Amgen Inc. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Amgen Inc. Main Business
Table 79. Amgen Inc. Latest Developments
Table 80. Novartis International AG Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 81. Novartis International AG CGRPTargeting Drugs for Migraine Product Offered
Table 82. Novartis International AG CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Novartis International AG Main Business
Table 84. Novartis International AG Latest Developments
Table 85. Daiichi Sankyo Co., Ltd. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 86. Daiichi Sankyo Co., Ltd. CGRPTargeting Drugs for Migraine Product Offered
Table 87. Daiichi Sankyo Co., Ltd. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Daiichi Sankyo Co., Ltd. Main Business
Table 89. Daiichi Sankyo Co., Ltd. Latest Developments
LIST OFFIGURES
Figure 1. CGRPTargeting Drugs for Migraine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CGRPTargeting Drugs for Migraine Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. CGRPTargeting Drugs for Migraine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. CGRPTargeting Drugs for Migraine Sales Market Share by Country/Region (2023)
Figure 8. CGRPTargeting Drugs for Migraine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global CGRPTargeting Drugs for Migraine Market Size Market Share byType in 2023
Figure 10. CGRPTargeting Drugs for Migraine in Hospital
Figure 11. Global CGRPTargeting Drugs for Migraine Market: Hospital (2019-2024) & ($ millions)
Figure 12. CGRPTargeting Drugs for Migraine in Specialty Clinic
Figure 13. Global CGRPTargeting Drugs for Migraine Market: Specialty Clinic (2019-2024) & ($ millions)
Figure 14. CGRPTargeting Drugs for Migraine in Others
Figure 15. Global CGRPTargeting Drugs for Migraine Market: Others (2019-2024) & ($ millions)
Figure 16. Global CGRPTargeting Drugs for Migraine Market Size Market Share by Application in 2023
Figure 17. Global CGRPTargeting Drugs for Migraine Revenue Market Share by Player in 2023
Figure 18. Global CGRPTargeting Drugs for Migraine Market Size Market Share by Region (2019-2024)
Figure 19. Americas CGRPTargeting Drugs for Migraine Market Size 2019-2024 ($ millions)
Figure 20. APAC CGRPTargeting Drugs for Migraine Market Size 2019-2024 ($ millions)
Figure 21. Europe CGRPTargeting Drugs for Migraine Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size 2019-2024 ($ millions)
Figure 23. Americas CGRPTargeting Drugs for Migraine Value Market Share by Country in 2023
Figure 24. United States CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC CGRPTargeting Drugs for Migraine Market Size Market Share by Region in 2023
Figure 29. APAC CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Figure 30. APAC CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Figure 31. China CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 35. India CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe CGRPTargeting Drugs for Migraine Market Size Market Share by Country in 2023
Figure 38. Europe CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Figure 39. Europe CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Figure 40. Germany CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 41.France CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 42. UK CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Figure 48. Egypt CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 51.Turkey CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 54. APAC CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 55. Europe CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 57. United States CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 58. Canada CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 59. Mexico CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 60. Brazil CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 61. China CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 62. Japan CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 63. Korea CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 65. India CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 66. Australia CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 67. Germany CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 68.France CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 69. UK CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 70. Italy CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 71. Russia CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 72. Egypt CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 73. South Africa CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 74. Israel CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 75.Turkey CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 77. Global CGRPTargeting Drugs for Migraine Market Size Market ShareForecast byType (2025-2030)
Figure 78. Global CGRPTargeting Drugs for Migraine Market Size Market ShareForecast by Application (2025-2030)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global CGRP Targeting Drugs for Migraine Market Size 2019-2030
2.1.2 CGRP Targeting Drugs for Migraine Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for CGRP Targeting Drugs for Migraine by Country/Region, 2019, 2023 & 2030
2.2 CGRP Targeting Drugs for Migraine Segment by Type
2.2.1 CGRP Receptor Antagonists
2.2.2 CGRP Monoclonal Antibodies
2.3 CGRP Targeting Drugs for Migraine Market Size by Type
2.3.1 CGRP Targeting Drugs for Migraine Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CGRP Targeting Drugs for Migraine Market Size Market Share by Type (2019-2024)
2.4 CGRP Targeting Drugs for Migraine Segment by Application
2.4.1 Hospital
2.4.2 Specialty Clinic
2.4.3 Others
2.5 CGRP Targeting Drugs for Migraine Market Size by Application
2.5.1 CGRP Targeting Drugs for Migraine Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CGRP Targeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
3 CGRP TARGETING DRUGS FOR MIGRAINE MARKET SIZE BY PLAYER
3.1 CGRP Targeting Drugs for Migraine Market Size Market Share by Player
3.1.1 Global CGRP Targeting Drugs for Migraine Revenue by Player (2019-2024)
3.1.2 Global CGRP Targeting Drugs for Migraine Revenue Market Share by Player (2019-2024)
3.2 Global CGRP Targeting Drugs for Migraine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CGRP TARGETING DRUGS FOR MIGRAINE BY REGION
4.1 CGRP Targeting Drugs for Migraine Market Size by Region (2019-2024)
4.2 Global CGRP Targeting Drugs for Migraine Annual Revenue by Country/Region (2019-2024)
4.3 Americas CGRP Targeting Drugs for Migraine Market Size Growth (2019-2024)
4.4 APAC CGRP Targeting Drugs for Migraine Market Size Growth (2019-2024)
4.5 Europe CGRP Targeting Drugs for Migraine Market Size Growth (2019-2024)
4.6 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024)
5.2 Americas CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024)
5.3 Americas CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CGRP Targeting Drugs for Migraine Market Size by Region (2019-2024)
6.2 APAC CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024)
6.3 APAC CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe CGRP Targeting Drugs for Migraine Market Size by Country (2019-2024)
7.2 Europe CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024)
7.3 Europe CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa CGRP Targeting Drugs for Migraine by Region (2019-2024)
8.2 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Type (2019-2024)
8.3 Middle East & Africa CGRP Targeting Drugs for Migraine Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CGRP TARGETING DRUGS FOR MIGRAINE MARKET FORECAST
10.1 Global CGRP Targeting Drugs for Migraine Forecast by Region (2025-2030)
10.1.1 Global CGRP Targeting Drugs for Migraine Forecast by Region (2025-2030)
10.1.2 Americas CGRP Targeting Drugs for Migraine Forecast
10.1.3 APAC CGRP Targeting Drugs for Migraine Forecast
10.1.4 Europe CGRP Targeting Drugs for Migraine Forecast
10.1.5 Middle East & Africa CGRP Targeting Drugs for Migraine Forecast
10.2 Americas CGRP Targeting Drugs for Migraine Forecast by Country (2025-2030)
10.2.1 United States Market CGRP Targeting Drugs for Migraine Forecast
10.2.2 Canada Market CGRP Targeting Drugs for Migraine Forecast
10.2.3 Mexico Market CGRP Targeting Drugs for Migraine Forecast
10.2.4 Brazil Market CGRP Targeting Drugs for Migraine Forecast
10.3 APAC CGRP Targeting Drugs for Migraine Forecast by Region (2025-2030)
10.3.1 China CGRP Targeting Drugs for Migraine Market Forecast
10.3.2 Japan Market CGRP Targeting Drugs for Migraine Forecast
10.3.3 Korea Market CGRP Targeting Drugs for Migraine Forecast
10.3.4 Southeast Asia Market CGRP Targeting Drugs for Migraine Forecast
10.3.5 India Market CGRP Targeting Drugs for Migraine Forecast
10.3.6 Australia Market CGRP Targeting Drugs for Migraine Forecast
10.4 Europe CGRP Targeting Drugs for Migraine Forecast by Country (2025-2030)
10.4.1 Germany Market CGRP Targeting Drugs for Migraine Forecast
10.4.2 France Market CGRP Targeting Drugs for Migraine Forecast
10.4.3 UK Market CGRP Targeting Drugs for Migraine Forecast
10.4.4 Italy Market CGRP Targeting Drugs for Migraine Forecast
10.4.5 Russia Market CGRP Targeting Drugs for Migraine Forecast
10.5 Middle East & Africa CGRP Targeting Drugs for Migraine Forecast by Region (2025-2030)
10.5.1 Egypt Market CGRP Targeting Drugs for Migraine Forecast
10.5.2 South Africa Market CGRP Targeting Drugs for Migraine Forecast
10.5.3 Israel Market CGRP Targeting Drugs for Migraine Forecast
10.5.4 Turkey Market CGRP Targeting Drugs for Migraine Forecast
10.6 Global CGRP Targeting Drugs for Migraine Forecast by Type (2025-2030)
10.7 Global CGRP Targeting Drugs for Migraine Forecast by Application (2025-2030)
10.7.1 GCC Countries Market CGRP Targeting Drugs for Migraine Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Information
11.1.2 AbbVie Inc. CGRP Targeting Drugs for Migraine Product Offered
11.1.3 AbbVie Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 AbbVie Inc. Main Business Overview
11.1.5 AbbVie Inc. Latest Developments
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Information
11.2.2 Pfizer Inc. CGRP Targeting Drugs for Migraine Product Offered
11.2.3 Pfizer Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Pfizer Inc. Main Business Overview
11.2.5 Pfizer Inc. Latest Developments
11.3 Lundbeck
11.3.1 Lundbeck Company Information
11.3.2 Lundbeck CGRP Targeting Drugs for Migraine Product Offered
11.3.3 Lundbeck CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Lundbeck Main Business Overview
11.3.5 Lundbeck Latest Developments
11.4 Alder Therapeutics
11.4.1 Alder Therapeutics Company Information
11.4.2 Alder Therapeutics CGRP Targeting Drugs for Migraine Product Offered
11.4.3 Alder Therapeutics CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Alder Therapeutics Main Business Overview
11.4.5 Alder Therapeutics Latest Developments
11.5 Teva
11.5.1 Teva Company Information
11.5.2 Teva CGRP Targeting Drugs for Migraine Product Offered
11.5.3 Teva CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Teva Main Business Overview
11.5.5 Teva Latest Developments
11.6 Lilly Inc.
11.6.1 Lilly Inc. Company Information
11.6.2 Lilly Inc. CGRP Targeting Drugs for Migraine Product Offered
11.6.3 Lilly Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Lilly Inc. Main Business Overview
11.6.5 Lilly Inc. Latest Developments
11.7 Amgen Inc.
11.7.1 Amgen Inc. Company Information
11.7.2 Amgen Inc. CGRP Targeting Drugs for Migraine Product Offered
11.7.3 Amgen Inc. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Amgen Inc. Main Business Overview
11.7.5 Amgen Inc. Latest Developments
11.8 Novartis International AG
11.8.1 Novartis International AG Company Information
11.8.2 Novartis International AG CGRP Targeting Drugs for Migraine Product Offered
11.8.3 Novartis International AG CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis International AG Main Business Overview
11.8.5 Novartis International AG Latest Developments
11.9 Daiichi Sankyo Co., Ltd.
11.9.1 Daiichi Sankyo Co., Ltd. Company Information
11.9.2 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Product Offered
11.9.3 Daiichi Sankyo Co., Ltd. CGRP Targeting Drugs for Migraine Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Daiichi Sankyo Co., Ltd. Main Business Overview
11.9.5 Daiichi Sankyo Co., Ltd. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. CGRPTargeting Drugs for Migraine Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. CGRPTargeting Drugs for Migraine Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CGRP Receptor Antagonists
Table 4. Major Players of CGRP Monoclonal Antibodies
Table 5. CGRPTargeting Drugs for Migraine Market Size CAGR byType (2019 VS 2023 VS 2030) & ($ millions)
Table 6. Global CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 7. Global CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Table 8. CGRPTargeting Drugs for Migraine Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 9. Global CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 10. Global CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Table 11. Global CGRPTargeting Drugs for Migraine Revenue by Player (2019-2024) & ($ millions)
Table 12. Global CGRPTargeting Drugs for Migraine Revenue Market Share by Player (2019-2024)
Table 13. CGRPTargeting Drugs for Migraine Key Players Head office and Products Offered
Table 14. CGRPTargeting Drugs for Migraine Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global CGRPTargeting Drugs for Migraine Market Size by Region (2019-2024) & ($ millions)
Table 18. Global CGRPTargeting Drugs for Migraine Market Size Market Share by Region (2019-2024)
Table 19. Global CGRPTargeting Drugs for Migraine Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global CGRPTargeting Drugs for Migraine Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas CGRPTargeting Drugs for Migraine Market Size by Country (2019-2024) & ($ millions)
Table 22. Americas CGRPTargeting Drugs for Migraine Market Size Market Share by Country (2019-2024)
Table 23. Americas CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 24. Americas CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Table 25. Americas CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 26. Americas CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Table 27. APAC CGRPTargeting Drugs for Migraine Market Size by Region (2019-2024) & ($ millions)
Table 28. APAC CGRPTargeting Drugs for Migraine Market Size Market Share by Region (2019-2024)
Table 29. APAC CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 30. APAC CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 31. Europe CGRPTargeting Drugs for Migraine Market Size by Country (2019-2024) & ($ millions)
Table 32. Europe CGRPTargeting Drugs for Migraine Market Size Market Share by Country (2019-2024)
Table 33. Europe CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 34. Europe CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 35. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size by Region (2019-2024) & ($ millions)
Table 36. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size byType (2019-2024) & ($ millions)
Table 37. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size by Application (2019-2024) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of CGRPTargeting Drugs for Migraine
Table 39. Key Market Challenges & Risks of CGRPTargeting Drugs for Migraine
Table 40. Key IndustryTrends of CGRPTargeting Drugs for Migraine
Table 41. Global CGRPTargeting Drugs for Migraine Market SizeForecast by Region (2025-2030) & ($ millions)
Table 42. Global CGRPTargeting Drugs for Migraine Market Size Market ShareForecast by Region (2025-2030)
Table 43. Global CGRPTargeting Drugs for Migraine Market SizeForecast byType (2025-2030) & ($ millions)
Table 44. Global CGRPTargeting Drugs for Migraine Market SizeForecast by Application (2025-2030) & ($ millions)
Table 45. AbbVie Inc. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 46. AbbVie Inc. CGRPTargeting Drugs for Migraine Product Offered
Table 47. AbbVie Inc. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 48. AbbVie Inc. Main Business
Table 49. AbbVie Inc. Latest Developments
Table 50. Pfizer Inc. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 51. Pfizer Inc. CGRPTargeting Drugs for Migraine Product Offered
Table 52. Pfizer Inc. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 53. Pfizer Inc. Main Business
Table 54. Pfizer Inc. Latest Developments
Table 55. Lundbeck Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 56. Lundbeck CGRPTargeting Drugs for Migraine Product Offered
Table 57. Lundbeck CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 58. Lundbeck Main Business
Table 59. Lundbeck Latest Developments
Table 60. AlderTherapeutics Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 61. AlderTherapeutics CGRPTargeting Drugs for Migraine Product Offered
Table 62. AlderTherapeutics CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. AlderTherapeutics Main Business
Table 64. AlderTherapeutics Latest Developments
Table 65.Teva Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 66.Teva CGRPTargeting Drugs for Migraine Product Offered
Table 67.Teva CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68.Teva Main Business
Table 69.Teva Latest Developments
Table 70. Lilly Inc. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 71. Lilly Inc. CGRPTargeting Drugs for Migraine Product Offered
Table 72. Lilly Inc. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Lilly Inc. Main Business
Table 74. Lilly Inc. Latest Developments
Table 75. Amgen Inc. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 76. Amgen Inc. CGRPTargeting Drugs for Migraine Product Offered
Table 77. Amgen Inc. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Amgen Inc. Main Business
Table 79. Amgen Inc. Latest Developments
Table 80. Novartis International AG Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 81. Novartis International AG CGRPTargeting Drugs for Migraine Product Offered
Table 82. Novartis International AG CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Novartis International AG Main Business
Table 84. Novartis International AG Latest Developments
Table 85. Daiichi Sankyo Co., Ltd. Details, CompanyType, CGRPTargeting Drugs for Migraine Area Served and Its Competitors
Table 86. Daiichi Sankyo Co., Ltd. CGRPTargeting Drugs for Migraine Product Offered
Table 87. Daiichi Sankyo Co., Ltd. CGRPTargeting Drugs for Migraine Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. Daiichi Sankyo Co., Ltd. Main Business
Table 89. Daiichi Sankyo Co., Ltd. Latest Developments
LIST OFFIGURES
Figure 1. CGRPTargeting Drugs for Migraine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global CGRPTargeting Drugs for Migraine Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. CGRPTargeting Drugs for Migraine Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. CGRPTargeting Drugs for Migraine Sales Market Share by Country/Region (2023)
Figure 8. CGRPTargeting Drugs for Migraine Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global CGRPTargeting Drugs for Migraine Market Size Market Share byType in 2023
Figure 10. CGRPTargeting Drugs for Migraine in Hospital
Figure 11. Global CGRPTargeting Drugs for Migraine Market: Hospital (2019-2024) & ($ millions)
Figure 12. CGRPTargeting Drugs for Migraine in Specialty Clinic
Figure 13. Global CGRPTargeting Drugs for Migraine Market: Specialty Clinic (2019-2024) & ($ millions)
Figure 14. CGRPTargeting Drugs for Migraine in Others
Figure 15. Global CGRPTargeting Drugs for Migraine Market: Others (2019-2024) & ($ millions)
Figure 16. Global CGRPTargeting Drugs for Migraine Market Size Market Share by Application in 2023
Figure 17. Global CGRPTargeting Drugs for Migraine Revenue Market Share by Player in 2023
Figure 18. Global CGRPTargeting Drugs for Migraine Market Size Market Share by Region (2019-2024)
Figure 19. Americas CGRPTargeting Drugs for Migraine Market Size 2019-2024 ($ millions)
Figure 20. APAC CGRPTargeting Drugs for Migraine Market Size 2019-2024 ($ millions)
Figure 21. Europe CGRPTargeting Drugs for Migraine Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size 2019-2024 ($ millions)
Figure 23. Americas CGRPTargeting Drugs for Migraine Value Market Share by Country in 2023
Figure 24. United States CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC CGRPTargeting Drugs for Migraine Market Size Market Share by Region in 2023
Figure 29. APAC CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Figure 30. APAC CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Figure 31. China CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 35. India CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe CGRPTargeting Drugs for Migraine Market Size Market Share by Country in 2023
Figure 38. Europe CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Figure 39. Europe CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Figure 40. Germany CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 41.France CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 42. UK CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size Market Share byType (2019-2024)
Figure 47. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size Market Share by Application (2019-2024)
Figure 48. Egypt CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 51.Turkey CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries CGRPTargeting Drugs for Migraine Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 54. APAC CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 55. Europe CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 57. United States CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 58. Canada CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 59. Mexico CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 60. Brazil CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 61. China CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 62. Japan CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 63. Korea CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 65. India CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 66. Australia CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 67. Germany CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 68.France CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 69. UK CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 70. Italy CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 71. Russia CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 72. Egypt CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 73. South Africa CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 74. Israel CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 75.Turkey CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries CGRPTargeting Drugs for Migraine Market Size 2025-2030 ($ millions)
Figure 77. Global CGRPTargeting Drugs for Migraine Market Size Market ShareForecast byType (2025-2030)
Figure 78. Global CGRPTargeting Drugs for Migraine Market Size Market ShareForecast by Application (2025-2030)
